Diana Spiegelberg

Ascorbate induces G2/M arrest and necrosis without  generation of direct DNA double-strand breaks

Hariri, Mehran; Papalanis, Eleftherios; Spiegelberg, Diana; Plotnikov, Evgenii et al.

Ingår i Heliyon, 2025

• DOI för Ascorbate induces G2/M arrest and necrosis without  generation of direct DNA double-strand breaks
• Ladda ner fulltext (pdf) av Ascorbate induces G2/M arrest and necrosis without  generation of direct DNA double-strand breaks

Enhancing glioblastoma therapy: unveiling synergistic anticancer effects of Onalespib - radiotherapy combination therapy

Uffenorde, Julia; Hariri, Mehran; Papalanis, Eleftherios; Staffas, Annika et al.

Ingår i Frontiers in Oncology, 2025

• DOI för Enhancing glioblastoma therapy: unveiling synergistic anticancer effects of Onalespib - radiotherapy combination therapy
• Ladda ner fulltext (pdf) av Enhancing glioblastoma therapy: unveiling synergistic anticancer effects of Onalespib - radiotherapy combination therapy

Copper-cysteamine nanoparticles in cancer treatment: a systematic review

Ejtema, Mahsa; Chegeni, Nahid; Langen, Britta; Marallu, Mousa Ahmadi et al.

Ingår i Cell Biology and Toxicology, 2025

• DOI för Copper-cysteamine nanoparticles in cancer treatment: a systematic review
• Ladda ner fulltext (pdf) av Copper-cysteamine nanoparticles in cancer treatment: a systematic review

Protocol for in vivo immune cell analysis in subcutaneous murine tumor models using advanced flow cytometry

Ingelshed, Katrine; Melssen, Marit M.; Spiegelberg, Diana

Ingår i STAR Protocols, 2025

• DOI för Protocol for in vivo immune cell analysis in subcutaneous murine tumor models using advanced flow cytometry
• Ladda ner fulltext (pdf) av Protocol for in vivo immune cell analysis in subcutaneous murine tumor models using advanced flow cytometry

In vitro measurement of proton RBE: A multi-centric comparison using a harmonized setup

Sokol, Olga; Frederiksen, Anders Tobias; Sitarz, Mateusz; Sørensen, Brita Singers et al.

Ingår i Clinical and Translational Radiation Oncology, 2025

• DOI för In vitro measurement of proton RBE: A multi-centric comparison using a harmonized setup
• Ladda ner fulltext (pdf) av In vitro measurement of proton RBE: A multi-centric comparison using a harmonized setup

Ascorbate induces G2/M arrest and necrosis without  generation of direct DNA double-strand breaks

Hariri, Mehran; Papalanis, Eleftherios; Spiegelberg, Diana; Plotnikov, Evgenii et al.

Ingår i Heliyon, 2025

• DOI för Ascorbate induces G2/M arrest and necrosis without  generation of direct DNA double-strand breaks
• Ladda ner fulltext (pdf) av Ascorbate induces G2/M arrest and necrosis without  generation of direct DNA double-strand breaks

Enhancing glioblastoma therapy: unveiling synergistic anticancer effects of Onalespib - radiotherapy combination therapy

Uffenorde, Julia; Hariri, Mehran; Papalanis, Eleftherios; Staffas, Annika et al.

Ingår i Frontiers in Oncology, 2025

• DOI för Enhancing glioblastoma therapy: unveiling synergistic anticancer effects of Onalespib - radiotherapy combination therapy
• Ladda ner fulltext (pdf) av Enhancing glioblastoma therapy: unveiling synergistic anticancer effects of Onalespib - radiotherapy combination therapy

Protocol for in vivo immune cell analysis in subcutaneous murine tumor models using advanced flow cytometry

Ingelshed, Katrine; Melssen, Marit M.; Spiegelberg, Diana

Ingår i STAR Protocols, 2025

• DOI för Protocol for in vivo immune cell analysis in subcutaneous murine tumor models using advanced flow cytometry
• Ladda ner fulltext (pdf) av Protocol for in vivo immune cell analysis in subcutaneous murine tumor models using advanced flow cytometry

In vitro measurement of proton RBE: A multi-centric comparison using a harmonized setup

Sokol, Olga; Frederiksen, Anders Tobias; Sitarz, Mateusz; Sørensen, Brita Singers et al.

Ingår i Clinical and Translational Radiation Oncology, 2025

• DOI för In vitro measurement of proton RBE: A multi-centric comparison using a harmonized setup
• Ladda ner fulltext (pdf) av In vitro measurement of proton RBE: A multi-centric comparison using a harmonized setup

Targeting mutant p53: Evaluation of novel anti-p53^R175H monoclonal antibodies as diagnostic tools

Spiegelberg, Diana; Hwang, Le-Ann; Pua, Khian Hong; Kumar, Sashwini Chandra et al.

Ingår i Scientific Reports, 2025

• DOI för Targeting mutant p53: Evaluation of novel anti-p53^R175H monoclonal antibodies as diagnostic tools
• Ladda ner fulltext (pdf) av Targeting mutant p53: Evaluation of novel anti-p53^R175H monoclonal antibodies as diagnostic tools

MDM2/MDMX inhibition by Sulanemadlin synergizes with anti-Programmed Death 1 immunotherapy in wild-type p53 tumors

Ingelshed, Katrine; Melssen, Marit M.; Kannan, Pavitra; Chandramohan, Arun et al.

Ingår i iScience, 2024

• DOI för MDM2/MDMX inhibition by Sulanemadlin synergizes with anti-Programmed Death 1 immunotherapy in wild-type p53 tumors
• Ladda ner fulltext (pdf) av MDM2/MDMX inhibition by Sulanemadlin synergizes with anti-Programmed Death 1 immunotherapy in wild-type p53 tumors

Design-rules for stapled peptides with in vivo activity and their application to Mdm2/X antagonists

Chandramohan, Arun; Josien, Hubert; Yuen, Tsz Ying; Duggal, Ruchia et al.

Ingår i Nature Communications, 2024

• DOI för Design-rules for stapled peptides with in vivo activity and their application to Mdm2/X antagonists
• Ladda ner fulltext (pdf) av Design-rules for stapled peptides with in vivo activity and their application to Mdm2/X antagonists

Utilizing CD44v6 and V600EBRAF-mutation for in vitro targeted combination therapy of thyroid carcinomas

Mortensen, Anja; Imgenberg-Kreuz, Juliana; Spiegelberg, Diana; Botling, J. et al.

Ingår i Heliyon, 2023

• DOI för Utilizing CD44v6 and V600EBRAF-mutation for in vitro targeted combination therapy of thyroid carcinomas
• Ladda ner fulltext (pdf) av Utilizing CD44v6 and V600EBRAF-mutation for in vitro targeted combination therapy of thyroid carcinomas

Combination therapy of tyrosine kinase inhibitor sorafenib with the HSP90 inhibitor onalespib as a novel treatment regimen for thyroid cancer

Lundgren Mortensen, Anja Charlotte; Berglund, Hanna; Hariri, Mehran; Papalanis, Eleftherios et al.

Ingår i Scientific Reports, 2023

• DOI för Combination therapy of tyrosine kinase inhibitor sorafenib with the HSP90 inhibitor onalespib as a novel treatment regimen for thyroid cancer
• Ladda ner fulltext (pdf) av Combination therapy of tyrosine kinase inhibitor sorafenib with the HSP90 inhibitor onalespib as a novel treatment regimen for thyroid cancer

Ra-223 induces clustered DNA damage and inhibits cell survival in several prostate cancer cell lines

Abramenkovs, Andris; Hariri, Mehran; Spiegelberg, Diana; Nilsson, Sten et al.

Ingår i Translational Oncology, 2022

• DOI för Ra-223 induces clustered DNA damage and inhibits cell survival in several prostate cancer cell lines
• Ladda ner fulltext (pdf) av Ra-223 induces clustered DNA damage and inhibits cell survival in several prostate cancer cell lines

Conformation specific antagonistic high affinity antibodies to the RON receptor kinase for imaging and therapy

Yu Koh, Xin; Koh, Xiao Hui; Spiegelberg, Diana; Jha, Preeti et al.

Ingår i Scientific Reports, 2022

• DOI för Conformation specific antagonistic high affinity antibodies to the RON receptor kinase for imaging and therapy
• Ladda ner fulltext (pdf) av Conformation specific antagonistic high affinity antibodies to the RON receptor kinase for imaging and therapy

The MDM2 Inhibitor Navtemadlin Arrests Mouse Melanoma Growth In Vivo and Potentiates Radiotherapy

Ingelshed, Katrine; Spiegelberg, Diana; Kannan, Pavitra; Påvénius, Linnéa et al.

Ingår i Cancer Research Communications, s. 1075-1088, 2022

• DOI för The MDM2 Inhibitor Navtemadlin Arrests Mouse Melanoma Growth In Vivo and Potentiates Radiotherapy
• Ladda ner fulltext (pdf) av The MDM2 Inhibitor Navtemadlin Arrests Mouse Melanoma Growth In Vivo and Potentiates Radiotherapy

Higher Risk of Recurrence in Patients Treated for Head and Neck Cancer with Low BMI and Elevated Levels of C-Reactive Protein

Spiegelberg, Diana; Malmberg, Christer; Ehrsson, Ylva Tiblom; Laurell, Göran

Ingår i Cancers, 2022

• DOI för Higher Risk of Recurrence in Patients Treated for Head and Neck Cancer with Low BMI and Elevated Levels of C-Reactive Protein
• Ladda ner fulltext (pdf) av Higher Risk of Recurrence in Patients Treated for Head and Neck Cancer with Low BMI and Elevated Levels of C-Reactive Protein

K-D determination from time-resolved experiments on live cells with LigandTracer and reconciliation with end-point flow cytometry measurements

Spiegelberg, Diana; Stenberg, Jonas; Richalet, Pascale; Vanhove, Marc

Ingår i European Biophysics Journal, s. 979-991, 2021

• DOI för K-D determination from time-resolved experiments on live cells with LigandTracer and reconciliation with end-point flow cytometry measurements
• Ladda ner fulltext (pdf) av K-D determination from time-resolved experiments on live cells with LigandTracer and reconciliation with end-point flow cytometry measurements

Overcoming Limitations of Cisplatin Therapy by Additional Treatment With the HSP90 Inhibitor Onalespib

Mortensen, Anja; Mohajershojai, Tabassom; Hariri, Mehran; Pettersson, Marika et al.

Ingår i Frontiers in Oncology, 2020

• DOI för Overcoming Limitations of Cisplatin Therapy by Additional Treatment With the HSP90 Inhibitor Onalespib
• Ladda ner fulltext (pdf) av Overcoming Limitations of Cisplatin Therapy by Additional Treatment With the HSP90 Inhibitor Onalespib

The Novel Anti-cMet Antibody seeMet 12 Potentiates Sorafenib Therapy and Radiotherapy in a Colorectal Cancer Model

Spiegelberg, Diana; Lundgren Mortensen, Anja Charlotte; Palupi, Kartika Dyah; Micke, Patrick et al.

Ingår i Frontiers in Oncology, 2020

• DOI för The Novel Anti-cMet Antibody seeMet 12 Potentiates Sorafenib Therapy and Radiotherapy in a Colorectal Cancer Model
• Ladda ner fulltext (pdf) av The Novel Anti-cMet Antibody seeMet 12 Potentiates Sorafenib Therapy and Radiotherapy in a Colorectal Cancer Model

The HSP90 inhibitor Onalespib exerts synergistic anti-cancer effects when combined with radiotherapy: an in vitro and in vivo approach

Spiegelberg, Diana; Abramenkovs, Andris; Mortensen, Anja; Lundsten, Sara et al.

Ingår i Scientific Reports, 2020

• DOI för The HSP90 inhibitor Onalespib exerts synergistic anti-cancer effects when combined with radiotherapy: an in vitro and in vivo approach
• Ladda ner fulltext (pdf) av The HSP90 inhibitor Onalespib exerts synergistic anti-cancer effects when combined with radiotherapy: an in vitro and in vivo approach

The radiosensitizer Onalespib increases complete remission in Lu-177-DOTATATE-treated mice bearing neuroendocrine tumor xenografts

Lundsten, Sara; Spiegelberg, Diana; Raval, Nakul; Nestor, Marika

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, s. 980-990, 2020

• DOI för The radiosensitizer Onalespib increases complete remission in Lu-177-DOTATATE-treated mice bearing neuroendocrine tumor xenografts
• Ladda ner fulltext (pdf) av The radiosensitizer Onalespib increases complete remission in Lu-177-DOTATATE-treated mice bearing neuroendocrine tumor xenografts

The Stapled Peptide PM2 Stabilizes p53 Levels and Radiosensitizes Wild-Type p53 Cancer Cells

Lundgren Mortensen, Anja; Spiegelberg, Diana; Brown, Christopher John; Lane, David Philip et al.

Ingår i Frontiers in Oncology, 2019

• DOI för The Stapled Peptide PM2 Stabilizes p53 Levels and Radiosensitizes Wild-Type p53 Cancer Cells
• Ladda ner fulltext (pdf) av The Stapled Peptide PM2 Stabilizes p53 Levels and Radiosensitizes Wild-Type p53 Cancer Cells

The HSP90 inhibitor onalespib potentiates Lu-177-DOTATATE therapy in neuroendocrine tumor cells

Lundsten, Sara; Spiegelberg, Diana; Stenerlöw, Bo; Nestor, Marika

Ingår i International Journal of Oncology, s. 1287-1295, 2019

• DOI för The HSP90 inhibitor onalespib potentiates Lu-177-DOTATATE therapy in neuroendocrine tumor cells
• Ladda ner fulltext (pdf) av The HSP90 inhibitor onalespib potentiates Lu-177-DOTATATE therapy in neuroendocrine tumor cells

Preclinical evaluation of a novel engineered recombinant human anti-CD44v6 antibody for potential use in radio-immunotherapy

Mortensen, Anja; Spiegelberg, Diana; Haylock, Anna-Karin; Lundqvist, Hans et al.

Ingår i International Journal of Oncology, s. 1875-1885, 2018

• DOI för Preclinical evaluation of a novel engineered recombinant human anti-CD44v6 antibody for potential use in radio-immunotherapy
• Ladda ner fulltext (pdf) av Preclinical evaluation of a novel engineered recombinant human anti-CD44v6 antibody for potential use in radio-immunotherapy

Ra223 induced clustered DNA damage reduces cell survival independently of androgen receptor variant 7 expression

Abramenkovs, Andris; Spiegelberg, Diana; Stenerlöw, Bo

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2018

First in vivo study of the MDM2/MDMX-p53 antagonist PM2 as potentiator of external radiotherapy in wt p53 cancer

Spiegelberg, Diana; Mortensen, Anja C.; Lundsten, Sara; Brown, C. J. et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2018

• DOI för First in vivo study of the MDM2/MDMX-p53 antagonist PM2 as potentiator of external radiotherapy in wt p53 cancer

Potentiating Lu-177-DOTATATE Therapy By HSP90 Inhibition - First In Vivo Study

Lundsten, Sara; Spiegelberg, Diana; Raval, Nakul; Stenerlöw, Bo et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2018

The MDM2/MDMX-p53 Antagonist PM2 Radiosensitizes Wild-Type p53 Tumors

Spiegelberg, Diana; Mortensen, Anja; Lundsten, Sara; Brown, Christopher J. et al.

Ingår i Cancer Research, s. 5084-5093, 2018

• DOI för The MDM2/MDMX-p53 Antagonist PM2 Radiosensitizes Wild-Type p53 Tumors

Radioiodination Of Small Stapled Peptides For p53 Therapy

Lundsten, Sara; Spiegelberg, Diana; Agmo Hernández, Víctor; Brown, C. et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2017

In Vivo Assessment of p53 Therapy as a Way of Enhancing Therapeutic Effects of Radiation

Mortensen, Anja C.; Spiegelberg, Diana; Lundsten, Sara; Brown, C. et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2017

The Novel, Stapled HDM2/HDMX-p53 Antagonist PM2 Has Potent Antitumorigenic Activities and Enhances the Effects of External Radiotherapy

Mortensen, Anja C.; Spiegelberg, Diana; Brown, C.; Lane, D. P. et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2017

The HSP90-inhibitor Onalespib Potentiates Lu-177-Dotatate Treatment of Neuroendocrine Tumors

Lundsten, Sara; Mortensen, Anja; Makiniemi, A.; Spiegelberg, Diana et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2017

In Vitro and In Vivo Growth Inhibitory and Radiosensitizing Effects of the Anti-HSP90 agent Onalespib

Spiegelberg, Diana; Lundsten, Sara; Mortensen, Anja C.; Abramenkovs, Andris et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2017

HSP90 inhibition in angiosarcoma

Spiegelberg, Diana

Ingår i British Journal of Dermatology, s. 343-344, 2017

• DOI för HSP90 inhibition in angiosarcoma

A real-time in vitro assay as a potential predictor of in vivo tumor imaging properties

Spiegelberg, Diana; Stenberg, Jonas; Haylock, Anna-Karin; Nestor, Marika

Ingår i Nuclear Medicine and Biology, s. 12-18, 2016

• DOI för A real-time in vitro assay as a potential predictor of in vivo tumor imaging properties

Evaluation of a novel type of imaging probe based on a recombinant bivalent mini-antibody construct for detection of CD44v6-expressing squamous cell carcinoma

Haylock, Anna-Karin; Spiegelberg, Diana; Mortensen, Anja C.; Selvaraju, Ram K. et al.

Ingår i International journal of oncology, s. 461-470, 2016

• DOI för Evaluation of a novel type of imaging probe based on a recombinant bivalent mini-antibody construct for detection of CD44v6-expressing squamous cell carcinoma
• Ladda ner fulltext (pdf) av Evaluation of a novel type of imaging probe based on a recombinant bivalent mini-antibody construct for detection of CD44v6-expressing squamous cell carcinoma

Molecular imaging of EGFR and CD44v6 for prediction and response monitoring of HSP90 inhibition in an in vivo squamous cell carcinoma model.

Spiegelberg, Diana; Mortensen, Anja C; Selvaraju, Ram K; Eriksson, Olof et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, s. 974-982, 2016

• DOI för Molecular imaging of EGFR and CD44v6 for prediction and response monitoring of HSP90 inhibition in an in vivo squamous cell carcinoma model.
• Ladda ner fulltext (pdf) av Molecular imaging of EGFR and CD44v6 for prediction and response monitoring of HSP90 inhibition in an in vivo squamous cell carcinoma model.

The novel HSP90 inhibitor AT13387 potentiates radiation effects in squamous cell carcinoma and adenocarcinoma cells

Spiegelberg, Diana; Dascalu, Adrian; Mortensen, Anja; Abramenkovs, Andris et al.

Ingår i Oncotarget, s. 35652-35666, 2015

• DOI för The novel HSP90 inhibitor AT13387 potentiates radiation effects in squamous cell carcinoma and adenocarcinoma cells
• Ladda ner fulltext (pdf) av The novel HSP90 inhibitor AT13387 potentiates radiation effects in squamous cell carcinoma and adenocarcinoma cells

Molecular imaging of EGFR and EGFRvIII for prediction and response monitoring of HSP90 inhibition in an in vivo squamous cell carcinoma model

Spiegelberg, Diana; Mortensen, Anja C.; Selvaraju, Ram Kumar; Eriksson, Olof et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2015

A real-time in vitro assay as a potential predictor of in vivo tumour imaging properties

Spiegelberg, Diana; Stenberg, J.; Haylock, Anna-Karin; Nestor, Marika

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2015

Improving EGFR imaging by use of an anti-EGFRvIII monoclonal antibody: characterizations in an in vivo squamous cell carcinoma model

Spiegelberg, Diana; Mortensen, Anja C.; Selvaraju, Ram Kumar; Stenberg, J. et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2015

Enhancing the effect of radiotherapy in cultured tumour cells using p53 therapy

Mortensen, Anja C.; Spiegelberg, Diana; Scott, A. M.; Lane, D. P. et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2015

In vivo characterization of the novel CD44v6-targeting Fab fragment AbD15179 for molecular imaging of squamous cell carcinoma: a dual-isotope study

Haylock, Anna-Karin; Spiegelberg, Diana; Nilvebrant, Johan; Sandström, Karl et al.

Ingår i EJNMMI Research, 2014

• DOI för In vivo characterization of the novel CD44v6-targeting Fab fragment AbD15179 for molecular imaging of squamous cell carcinoma: a dual-isotope study
• Ladda ner fulltext (pdf) av In vivo characterization of the novel CD44v6-targeting Fab fragment AbD15179 for molecular imaging of squamous cell carcinoma: a dual-isotope study

Impact of Conjugation of Antibodies and Antibody Fragments on Their Interaction With Target Antigens on Living Cells

Stenberg, Jonas; Bondza, Sina; Spiegelberg, Diana; Björkelund, Hanna et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2014

Evaluation of cancer stem cell markers CD133, CD44, CD24: association with AKT isoforms and radiation resistance in colon cancer cells.

Häggblad Sahlberg, Sara; Spiegelberg, Diana; Glimelius, Bengt; Stenerlöw, Bo et al.

Ingår i PLOS ONE, 2014

• DOI för Evaluation of cancer stem cell markers CD133, CD44, CD24: association with AKT isoforms and radiation resistance in colon cancer cells.
• Ladda ner fulltext (pdf) av Evaluation of cancer stem cell markers CD133, CD44, CD24: association with AKT isoforms and radiation resistance in colon cancer cells.

Characterization of CD44 variant expression in head and neck squamous cell carcinomas

Spiegelberg, Diana; Kuku, Gamze; Selvaraju, Ram; Nestor, Marika

Ingår i Tumor Biology, s. 2053-2062, 2014

• DOI för Characterization of CD44 variant expression in head and neck squamous cell carcinomas
• Ladda ner fulltext (pdf) av Characterization of CD44 variant expression in head and neck squamous cell carcinomas

Determination of receptor protein binding site specificity and relative binding strength using a time-resolved competition assay

Barta, Pavel; Volkova, Marie; Dascalu, Adrian; Spiegelberg, Diana et al.

Ingår i Journal of pharmacological and toxicological methods, s. 145-151, 2014

• DOI för Determination of receptor protein binding site specificity and relative binding strength using a time-resolved competition assay

Choice of labeling and cell line influences interactions between the Fab fragment AbD15179 and its target antigen CD44v6

Stenberg, Jonas; Spiegelberg, Diana; Karlsson, Hampus; Nestor, Marika

Ingår i Nuclear Medicine and Biology, s. 140-147, 2014

• DOI för Choice of labeling and cell line influences interactions between the Fab fragment AbD15179 and its target antigen CD44v6

In vivo characterization of a novel engineered CD44v6-targeting bivalent antibody fragment AbD19384 for molecular imaging of squamous cell carcinoma

Mortensen, Anja C.; Spegelberg, Diana; Haylock, Anna-Karin; Selvaraju, Ram Kumar et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2014

Evaluation of biomarkers for imaging and radio-immunotherapy in combination with HSP90 inhibition in squamous cell carcinomas

Spiegelberg, Diana; Mortensen, Anja C.; Haylock, Anna-Karin; Selvaraju, Ram Kumar et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2014

In vivo characterization of CD44v6-targeting Fab fragments for molecular imaging of squamous cell carcinoma: a dual isotope study

Spiegelberg, Diana; Haylock, Anna-Karin; Nestor, Marika

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2013

The effect of a dimeric Affibody molecule (ZEGFR:1907)2 targeting EGFR in combination with radiation in colon cancer cell lines

Häggblad Sahlberg, Sara; Spiegelberg, Diana; Lennartsson, Johan; Nygren, Peter et al.

Ingår i International Journal of Oncology, s. 176-184, 2012

• DOI för The effect of a dimeric Affibody molecule (ZEGFR:1907)2 targeting EGFR in combination with radiation in colon cancer cell lines
• Ladda ner fulltext (pdf) av The effect of a dimeric Affibody molecule (ZEGFR:1907)2 targeting EGFR in combination with radiation in colon cancer cell lines

A novel CD44v6 targeting antibody fragment with improved tumor-to-blood ratio

Sandström, Karl; Haylock, Anna-Karin; Spiegelberg, Diana; Qvarnström, Fredrik et al.

Ingår i International Journal of Oncology, s. 1525-1532, 2012

• DOI för A novel CD44v6 targeting antibody fragment with improved tumor-to-blood ratio

Characterization of CD44 Variant Expression in Cultured Head & Neck Squamous Cell Carcinomas for Possible Use in Radio-Immunotargeting

Spiegelberg, Diana; Nestor, Marika

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2012

Improved Tumor-to-Organ Ratios of a Novel ⁶⁷Ga-Human Epidermal Growth Factor Radionuclide Conjugate with Preadministered Antiepidermal Growth Factor Receptor Affibody Molecules

Sandström, Karl; Haylock, Anna-Karin; Velikyan, Irina; Spiegelberg, Diana et al.

Ingår i Cancer Biotherapy and Radiopharmaceuticals, s. 593-601, 2011

• DOI för Improved Tumor-to-Organ Ratios of a Novel ⁶⁷Ga-Human Epidermal Growth Factor Radionuclide Conjugate with Preadministered Antiepidermal Growth Factor Receptor Affibody Molecules

Molecular imaging of CD44v6-expressing squamous cell carcinoma using a novel engineered bivalent antibody fragment

Haylock, Anna-Karin; Spiegelberg, Diana; Mortensen, Anja; Selvaraju, Ram Kumar et al.

Copper-cysteamine nanoparticles in cancer treatment: a systematic review

Ejtema, Mahsa; Chegeni, Nahid; Langen, Britta; Marallu, Mousa Ahmadi et al.

Ingår i Cell Biology and Toxicology, 2025

• DOI för Copper-cysteamine nanoparticles in cancer treatment: a systematic review
• Ladda ner fulltext (pdf) av Copper-cysteamine nanoparticles in cancer treatment: a systematic review

CD44v6-Targeted Imaging of Head and Neck Squamous Cell Carcinoma: Antibody-Based Approaches

Spiegelberg, Diana; Nilvebrant, Johan

Ingår i Contrast Media & Molecular Imaging, 2017

• DOI för CD44v6-Targeted Imaging of Head and Neck Squamous Cell Carcinoma: Antibody-Based Approaches
• Ladda ner fulltext (pdf) av CD44v6-Targeted Imaging of Head and Neck Squamous Cell Carcinoma: Antibody-Based Approaches

Towards Personalized Cancer Therapy: New Diagnostic Biomarkers and Radiosensitization Strategies

Spiegelberg, Diana

2015

• Ladda ner fulltext (pdf) av Towards Personalized Cancer Therapy: New Diagnostic Biomarkers and Radiosensitization Strategies

Evaluation of biomarkers for imaging and radio-immunotherapy in combination with HSP90 inhibition in squamous cell carcinomas

Spiegelberg, Diana; Mortensen, Anja; Selvaraju, Ram Kumar; Eriksson, Olof et al.

The α-emitter Ra-223 induces clustered DNA damage and significantly reduces cell survival

Abramenkovs, Andris; Spiegelberg, Diana; Nilsson, Sten; Stenerlöw, Bo

Therapeutic combination of HSP90 inhibition and radiation therapy reduces tumor growth in a syngeneic neuroblastoma mouse model.

Berglund, Hanna; Pereira, Beatriz; Nestor, Marika; Spiegelberg, Diana